Upcoming Webinars

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 1)

Biotech, Cell & Gene Therapy, Drug Discovery & Development, Laboratory Technology, Life Science, Pharma, Pharma Manufacturing & Supply Chain,
  • February 24, 2026 | 8am GMT (UK) / 9am CET (EU-Central) / 4pm CST (China) / 5pm JST (Japan) / 5pm KST (Korea)
  • 60 min

Upcoming Webinars

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 2)

Biotech, Cell & Gene Therapy, Drug Discovery & Development, Laboratory Technology, Life Science, Pharma, Pharma Manufacturing & Supply Chain,
  • February 24, 2026 | 8am EST (N. America) / 1pm GMT (UK) / 2pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Addressing Rising LQPPV and Lifecycle Management Demands Using Applied AI

Biotech, Drug Safety, Life Science, Pharma, Pharmaceutical Regulation, Pharmacovigilance,
  • February 24, 2026 | 10am EST (NA) / 3pm GMT (UK) / 4pm CEST (EU-Central)
  • 60 min

Upcoming Webinars

How Moderna Uses Decision Intelligence to Enable an Autonomous Cold Chain

Biotech, Life Science, Pharma, Pharma Manufacturing & Supply Chain,
  • February 24, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • February 25, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 1)
February 24, 2026

Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0 (Broadcast 2)
February 24, 2026

Addressing Rising LQPPV and Lifecycle Management Demands Using Applied AI
Hero-Banner-1600
February 24, 2026

How Moderna Uses Decision Intelligence to Enable an Autonomous Cold Chain
February 25, 2026

Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights
February 25, 2026

From FIH to POC — Designing Phase I/Ib Trials with Efficiency
February 26, 2026

Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know
February 26, 2026

Engaging Community Voices to Improve Clinical Trial Access
February 26, 2026

How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics
February 27, 2026

Peptide Synthesis: New Sustainable Strategies for Regulatory and Market Demands
February 27, 2026

3 Key Trends Transforming the Future of Rare Disease Clinical Development
February 27, 2026

Overcoming Disruptions in the Life Sciences Supply Chain with Unified Platforms
March 03, 2026

When patients lead: Breaking barriers in ultra-rare disease drug development
March 03, 2026

Embracing the Transformative Role of AI in Driving RWD Adoption
March 04, 2026

Secure Cryogenic Transport with Novel Approaches for Preventing Blood Bag Breakage
March 04, 2026

Accelerate Your Study: Harnessing AI and Automation for Rapid Study Start-up